Agios to Webcast Conference Call of Fourth Quarter and Full Year 2019 Financial Results on February 13, 2020
January 30 2020 - 7:00AM
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field
of cellular metabolism to treat cancer and rare genetic diseases,
today announced that the company will host a conference call and
live webcast on Thursday, February 13, 2020 at 8:00 a.m. ET to
report its fourth quarter and full year 2019 financial results and
other business highlights.
A live webcast can be accessed under "Events &
Presentations" in the Investors section of the company's website at
www.agios.com. The conference call can be accessed by dialing
1-877-377-7098 (domestic) or 1-631-291-4547 (international) and
referring to conference ID 4195413. The webcast will be archived
and made available for replay on the company's website beginning
approximately two hours after the event.
About AgiosAgios is focused on discovering and
developing novel investigational medicines to treat malignant
hematology, solid tumors and rare genetic diseases through
scientific leadership in the field of cellular metabolism. In
addition to an active research and discovery pipeline across these
three therapeutic areas, Agios has two approved oncology precision
medicines and multiple first-in-class investigational therapies in
clinical and/or preclinical development. For more information,
please visit the company's website at www.agios.com.
Contacts
Investors:Holly Manning, 617-844-6630Associate
Director, Investor RelationsHolly.Manning@agios.com
Media:Jessica Rennekamp, 857-209-3286Associate
Director, Corporate CommunicationsJessica.Rennekamp@agios.com
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Sep 2023 to Sep 2024